PATENT CLAIM ANALYSIS

Application Number: 15755618
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-08
Patent Classification: ["514", "048000"]

Abstract:
Provided are a new crystal form of fludarabine phosphate, a preparation method therefor, a pharmaceutical composition containing same, and an application thereof in preparing medicine. Crystal forms I and II of the fludarabine phosphate have excellent properties in terms of solubleness, dissolution rate, chemical stability, and processing adaptability.

Claim (Index 2):
The crystal form I according to  claim 1 , wherein the X-ray powder diffraction pattern thereof has characteristic peaks at 2\u03b8 (\u00b0) values of 6.2\u00b10.2, 10.5\u00b10.2, 12.3\u00b10.2, 18.9\u00b10.2, 26.3\u00b10.2.

Metadata:
- Claim Count in Document: 9.0
- Percentile: 88.0
- Lexical Diversity: 1.36585
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15760090', '15762895', '15328795', '15123378', '16098103']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7915486640085909
- 35 USC 102 Novelty (BERT): 0.4938458890500069
- Combined Prediction Score: 0.7617783865127326
- Mean Citation Score: 231.988772
- Max Citation Score: 248.48439
- Similarity Product: 199.38550197301623

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test